113 related articles for article (PubMed ID: 14530473)
1. Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning.
Li ST; Holmes C; Kopin IJ; Goldstein DS
J Nucl Med; 2003 Oct; 44(10):1599-603. PubMed ID: 14530473
[TBL] [Abstract][Full Text] [Related]
2. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure.
Tipre DN; Goldstein DS
J Nucl Med; 2005 Nov; 46(11):1775-81. PubMed ID: 16269589
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans.
Goldstein DS; Eisenhofer G; Dunn BB; Armando I; Lenders J; Grossman E; Holmes C; Kirk KL; Bacharach S; Adams R
J Am Coll Cardiol; 1993 Dec; 22(7):1961-71. PubMed ID: 8245356
[TBL] [Abstract][Full Text] [Related]
4. Kinetic model for the fate of 6-[18F]fluorodopamine in the human heart: a novel means to examine cardiac sympathetic neuronal function.
Goldstein DS; Katzper M; Linares O; Kopin IJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):38-49. PubMed ID: 11862332
[TBL] [Abstract][Full Text] [Related]
5. 6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function--studies in normal humans.
Goldstein DS; Holmes C; Stuhlmuller JE; Lenders JW; Kopin IJ
Clin Auton Res; 1997 Feb; 7(1):17-29. PubMed ID: 9074825
[TBL] [Abstract][Full Text] [Related]
6. Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine.
Goldstein DS; Grossman E; Tamrat M; Chang PC; Eisenhofer G; Bacher J; Kirk KL; Bacharach S; Kopin IJ
J Hypertens; 1991 May; 9(5):417-23. PubMed ID: 1649861
[TBL] [Abstract][Full Text] [Related]
7. 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans.
Goldstein DS; Coronado L; Kopin IJ
J Nucl Med; 1994 Jun; 35(6):964-73. PubMed ID: 8195883
[TBL] [Abstract][Full Text] [Related]
8. Sympathetic cardioneuropathy in dysautonomias.
Goldstein DS; Holmes C; Cannon RO; Eisenhofer G; Kopin IJ
N Engl J Med; 1997 Mar; 336(10):696-702. PubMed ID: 9041100
[TBL] [Abstract][Full Text] [Related]
9. Cardiac sympathetic hypo-innervation in familial dysautonomia.
Goldstein DS; Eldadah B; Sharabi Y; Axelrod FB
Clin Auton Res; 2008 Jun; 18(3):115-9. PubMed ID: 18498023
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution and kinetics of [18F]6-flurodopamine as a measure of cardiac sympathetic activity in humans.
Coates G; Chirakal R; Fallen EL; Firnau G; Garnett ES; Kamath MV; Scheffel A; Nahmias C
Heart; 1996 Jan; 75(1):29-34. PubMed ID: 8624867
[TBL] [Abstract][Full Text] [Related]
11. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Goldstein DS; Holmes C; Frank SM; Dendi R; Cannon RO; Sharabi Y; Esler MD; Eisenhofer G
Circulation; 2002 Oct; 106(18):2358-65. PubMed ID: 12403667
[TBL] [Abstract][Full Text] [Related]
12. Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy.
Li ST; Tack CJ; Fananapazir L; Goldstein DS
J Am Coll Cardiol; 2000 Jun; 35(7):1867-73. PubMed ID: 10841237
[TBL] [Abstract][Full Text] [Related]
13. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomographic imaging of cardiac sympathetic innervation and function.
Goldstein DS; Chang PC; Eisenhofer G; Miletich R; Finn R; Bacher J; Kirk KL; Bacharach S; Kopin IJ
Circulation; 1990 May; 81(5):1606-21. PubMed ID: 2331769
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sympathetic denervation in Parkinson disease.
Goldstein DS; Holmes C; Li ST; Bruce S; Metman LV; Cannon RO
Ann Intern Med; 2000 Sep; 133(5):338-47. PubMed ID: 10979878
[TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans.
Goldstein DS; Holmes C
Clin Exp Hypertens; 1997; 19(1-2):155-61. PubMed ID: 9028643
[TBL] [Abstract][Full Text] [Related]
17. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine.
Goldstein DS; Chang PC; Smith CB; Herscovitch P; Austin SM; Eisenhofer G; Kopin IJ
J Nucl Med; 1991 Jan; 32(1):102-10. PubMed ID: 1988612
[TBL] [Abstract][Full Text] [Related]
19. Partial cardiac sympathetic denervation after bilateral thoracic sympathectomy in humans.
Moak JP; Eldadah B; Holmes C; Pechnik S; Goldstein DS
Heart Rhythm; 2005 Jun; 2(6):602-9. PubMed ID: 15922266
[TBL] [Abstract][Full Text] [Related]
20. Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction.
Fallen EL; Coates G; Nahmias C; Chirakal R; Beanlands R; Wahl L; Woodcock G; Thomson M; Kamath M
Am Heart J; 1999 May; 137(5):863-9. PubMed ID: 10220635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
